BTAI
Price:
$0.3464
Market Cap:
$17.19M
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials e...[Read more]
Industry
Biotechnology
IPO Date
2018-03-08
Stock Exchange
NASDAQ
Ticker
BTAI
According to BioXcel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.87. This represents a change of -20.75% compared to the average of 2.36 of the last 4 quarters.
The mean historical Current Ratio of BioXcel Therapeutics, Inc. over the last ten years is 6.09. The current 1.87 Current Ratio has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), BTAI's Current Ratio was at its highest in in the June 2018 quarter at 36.78. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
6.09
Median
4.03
Minimum
0
Maximum
18.33
Discovering the peaks and valleys of BioXcel Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 18.33
Minimum Annual Increase = -57.09%
Minimum Annual Current Ratio = 0
Year | Current Ratio | Change |
---|---|---|
2023 | 2.65 | -57.09% |
2022 | 6.17 | -55.88% |
2021 | 13.98 | -23.74% |
2020 | 18.33 | 355.10% |
2019 | 4.03 | -56.52% |
2018 | 9.26 | 2.33% |
2017 | 0.38 | 6.20% |
2016 | 0.01 | Infinity% |
The current Current Ratio of BioXcel Therapeutics, Inc. (BTAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.60
5-year avg
9.03
10-year avg
6.09
BioXcel Therapeutics, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (32.99), less than Amylyx Pharmaceuticals, Inc. (4.55), less than Acumen Pharmaceuticals, Inc. (10.43), less than Inozyme Pharma, Inc. (7.68), less than X4 Pharmaceuticals, Inc. (4.89), less than Day One Biopharmaceuticals, Inc. (14.62), less than Mirati Therapeutics, Inc. (7.54), less than Apellis Pharmaceuticals, Inc. (4.36), less than Exelixis, Inc. (3.93), less than TG Therapeutics, Inc. (4.59), less than Viking Therapeutics, Inc. (36.47), less than Madrigal Pharmaceuticals, Inc. (5.98), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Elevation Oncology, Inc. (17.77), less than Mereo BioPharma Group plc (6.10), greater than Hepion Pharmaceuticals, Inc. (1.30),
Company | Current Ratio | Market cap |
---|---|---|
32.99 | $503.69M | |
4.55 | $278.99M | |
10.43 | $106.34M | |
7.68 | $193.36M | |
4.89 | $98.42M | |
14.62 | $1.28B | |
7.54 | $4.12B | |
4.36 | $4.13B | |
3.93 | $9.56B | |
4.59 | $5.02B | |
36.47 | $4.72B | |
5.98 | $6.78B | |
1.03 | $941.00 | |
17.77 | $33.90M | |
6.10 | $524.55M | |
1.30 | $3.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioXcel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioXcel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is BioXcel Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for BioXcel Therapeutics, Inc. (BTAI)?
What is the highest Current Ratio for BioXcel Therapeutics, Inc. (BTAI)?
What is the 3-year average Current Ratio for BioXcel Therapeutics, Inc. (BTAI)?
What is the 5-year average Current Ratio for BioXcel Therapeutics, Inc. (BTAI)?
How does the current Current Ratio for BioXcel Therapeutics, Inc. (BTAI) compare to its historical average?